Literature DB >> 6426943

A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures.

C Marescaux, G Micheletti, M Vergnes, A Depaulis, L Rumbach, J M Warter.   

Abstract

Of 100 randomly chosen, adult male Wistar rats in the breeding colony at the Centre de Neurochimie , Strasbourg, 31 presented spontaneous, nonconvulsive epileptic seizures: wave-and-spike discharges, 7-11 cycles/s, 200-600 microV, accompanied by behavioral arrest and myoclony of the vibrissae and of the facial and cervical muscles. Pentylenetetrazol (PTZ) 10 and 20 mg/kg increased the duration and number of seizures by 100-150% in these spontaneously epileptic animals, and caused identical seizures in apparently normal rats. Sodium valproate, diazepam, trimethadione, and ethosuximide suppressed the spontaneous seizures and protected against PTZ-induced seizures in a dose-dependent fashion. Carbamazepine and diphenylhydantoin were inefficacious or aggravative in the two cases. The clinical, EEG, and pharmacological observations suggest that the Wistar rats displaying spontaneous seizures constitute a valid physiological and pharmacological model of petit mal absences, presenting advantages compared to the usual models in which seizures are induced by injected epileptogenic drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426943     DOI: 10.1111/j.1528-1157.1984.tb04196.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  Antiepileptogenic agents: how close are we?

Authors:  N R Temkin; A D Jarell; G D Anderson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Convulsive activity in the electroencephalogram in rats sensitive and tolerant to pentylenetetrazol kindling.

Authors:  T V Pavlova; G N Fesenko; A B Gekht; N V Gulyaeva; V M Koval'zon
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

3.  Pentylenetetrazol-induced spike wave discharges in rats: a polygraphic study.

Authors:  G Gallitto; R Musolino; G Aliquò; A Bruno; P De Domenico; C E Marlara; L Marabello; R M Puglisi; R Sturniolo; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1987-04

4.  Seeking potential anticonvulsant agents that target GABAA receptors using experimental and theoretical procedures.

Authors:  Margarita Virginia Saavedra-Vélez; José Correa-Basurto; Myrna H Matus; Eloy Gasca-Pérez; Martiniano Bello; Roberto Cuevas-Hernández; Rosa Virginia García-Rodríguez; José Trujillo-Ferrara; Fernando Rafael Ramos-Morales
Journal:  J Comput Aided Mol Des       Date:  2014-10-09       Impact factor: 3.686

5.  Cellular and network mechanisms of genetically-determined absence seizures.

Authors:  Didier Pinault; Terence J O'Brien
Journal:  Thalamus Relat Syst       Date:  2007-01-22

6.  Genetic Absence Epilepsy in Rats from Strasbourg (GAERS).

Authors:  C Marescaux; M Vergnes
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

7.  Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.

Authors:  D Colas; B Chuluun; D Warrier; M Blank; D Z Wetmore; P Buckmaster; C C Garner; H C Heller
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 8.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

9.  The GABA(A) Receptor: Subunit-Dependent Functions and Absence Seizures.

Authors:  C Guin-Ting Wong; O Carter Snead
Journal:  Epilepsy Curr       Date:  2001-09       Impact factor: 7.500

10.  Blockade of "antiabsence" activity of sodium valproate by THIP in rats with petit mal-like seizures. Comparison with ethosuximide.

Authors:  M Vergnes; C Marescaux; G Micheletti; L Rumbach; J M Warter
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.